These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3467875)
21. Pharmacokinetics of norfloxacin in chronic renal failure. Arrigo G; Cavaliere G; D'Amico G; Passarella E; Broccali G Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):491-6. PubMed ID: 4055162 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic profile of a new 3-azinomethyl rifamycin (SPA-S-565) in volunteers as compared with conventional rifampicin. Kelkar MS; Saraf AP; Bakhle DS; Nazare V; Ajay S; Hegde S; Lal HM; Cooverji ND; Bruzzese T Int J Clin Pharmacol Res; 1998; 18(3):137-43. PubMed ID: 9825270 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of buflomedil after intravenous administration in patients with chronic renal failure. Rey E; d'Athis P; Richard MO; Fillastre JP; Olive G Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):648-52. PubMed ID: 6526539 [TBL] [Abstract][Full Text] [Related]
24. Clinical pharmacokinetics of digoxin in Nigerians. Iyun AO; Lukanbi FA Afr J Med Med Sci; 1988 Mar; 17(1):9-15. PubMed ID: 2834936 [TBL] [Abstract][Full Text] [Related]
25. [Prostatic tissue and fluid levels of DL-8280]. Kumon H; Furukawa M; Mizuno A; Miyata K; Akazawa N; Ohmori H; Katayama Y; Akaeda T Hinyokika Kiyo; 1984 Sep; 30(9):1297-305. PubMed ID: 6596879 [TBL] [Abstract][Full Text] [Related]
26. The effect of food on the pharmacokinetics of ofloxacin. Verho M; Malerczyk V; Dagrosa E; Korn A Curr Med Res Opin; 1986; 10(3):166-71. PubMed ID: 3460737 [TBL] [Abstract][Full Text] [Related]
27. Effects of ketoprofen (NSAID) on the pharmacokinetics of pefloxacin and ofloxacin in healthy volunteers. Fillastre JP; Leroy A; Borsa-Lebas F; Etienne I; Gy C; Humbert G Drugs Exp Clin Res; 1992; 18(11-12):487-92. PubMed ID: 1308475 [TBL] [Abstract][Full Text] [Related]
29. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects. Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463 [TBL] [Abstract][Full Text] [Related]
30. Influence of age on the pharmacokinetics of naftidrofuryl after single oral administration in elderly versus young healthy volunteers. Hulot T; Gamand S; Dupain T; Ahtoy P; Bromet M Arzneimittelforschung; 1998 Sep; 48(9):900-4. PubMed ID: 9793615 [TBL] [Abstract][Full Text] [Related]
31. No need to adjust the dose of 311C90 (zolmitriptan), a novel anti-migraine treatment, in patients with renal failure not requiring dialysis. Gillotin C; Bagnis C; Mamet JP; Peck RW; Deray G Int J Clin Pharmacol Ther; 1997 Nov; 35(11):522-6. PubMed ID: 9401835 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of nitrendipine in patients with renal failure: comparison to normal subjects. Aronoff GR J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S974-6. PubMed ID: 6085387 [TBL] [Abstract][Full Text] [Related]
33. [Determination of levofloxacin in plasma and cerebrospinal fluid with HPLC and its pharmacokinetics in patients undergoing neurosurgical operations]. Luo S; Lei J; Zhang R; Cai H; Li R Yao Xue Xue Bao; 1998 Dec; 33(12):937-40. PubMed ID: 12016861 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of ofloxacin and theophylline alone and in combination. Fourtillan JB; Granier J; Saint-Salvi B; Salmon J; Surjus A; Tremblay D; Vincent Du Laurier M; Beck S Infection; 1986; 14 Suppl 1():S67-9. PubMed ID: 3456985 [TBL] [Abstract][Full Text] [Related]
35. Preliminary pharmacokinetic and clinical evaluation of ofloxacin in dental and oral cavity diseases. Pappalardo G; Bianchi A; Scire Scappuzzo G; Mirone M; Salomone S Int J Clin Pharmacol Res; 1989; 9(3):229-32. PubMed ID: 2663738 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of a new oral antibacterial agent, ofloxacin, in dentistry and oral surgery. Bedeschi G; Beltrame M; Baldin C; Confente G; Guerra L; Fostini R Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):162-4. PubMed ID: 3165967 [TBL] [Abstract][Full Text] [Related]
37. The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin. Wise R; Lister D; McNulty CA; Griggs D; Andrews JM Infection; 1986; 14 Suppl 3():S196-202. PubMed ID: 3463542 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of pipemidic acid in healthy middle-aged volunteers and elderly patients with renal insufficiency. Männistö P; Solkinen A; Mäntylä R; Gordin A; Salo H; Hänninen U; Niinistö L Xenobiotica; 1984 Apr; 14(4):339-47. PubMed ID: 6464503 [TBL] [Abstract][Full Text] [Related]
39. Renal tolerance of ofloxacin, a new gyrase inhibitor. Verho M; Dagrosa EE; Usinger P; Grötsch H; Malerczyk V; Uchida M; Rangoonwala R Pharmatherapeutica; 1985; 4(5):306-13. PubMed ID: 2866542 [TBL] [Abstract][Full Text] [Related]
40. Diffusion of oral ofloxacin (HOE 280) into human prostatic tissue: assessment by an improved high-performance liquid chromatographic method. Claes R; Dusart Y; Dupont JC; Jeanbaptiste B; Podoor M; Douchamps J Infection; 1986; 14 Suppl 4():S263-5. PubMed ID: 3469159 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]